GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (OSTO:CMH) » Definitions » EV-to-Revenue

Chordate Medical Holding AB (OSTO:CMH) EV-to-Revenue : 5.83 (As of Jun. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Chordate Medical Holding AB's enterprise value is kr6.50 Mil. Chordate Medical Holding AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr1.11 Mil. Therefore, Chordate Medical Holding AB's EV-to-Revenue for today is 5.83.

The historical rank and industry rank for Chordate Medical Holding AB's EV-to-Revenue or its related term are showing as below:

OSTO:CMH' s EV-to-Revenue Range Over the Past 10 Years
Min: -3.95   Med: 128.28   Max: 301.39
Current: 5.83

During the past 9 years, the highest EV-to-Revenue of Chordate Medical Holding AB was 301.39. The lowest was -3.95. And the median was 128.28.

OSTO:CMH's EV-to-Revenue is ranked worse than
71.15% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: 3.1 vs OSTO:CMH: 5.83

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-11), Chordate Medical Holding AB's stock price is kr0.0552. Chordate Medical Holding AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.01. Therefore, Chordate Medical Holding AB's PS Ratio for today is 11.04.


Chordate Medical Holding AB EV-to-Revenue Historical Data

The historical data trend for Chordate Medical Holding AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB EV-to-Revenue Chart

Chordate Medical Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only - - - 819.53 29.53

Chordate Medical Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 564.13 264.17 108.18 29.53 11.31

Competitive Comparison of Chordate Medical Holding AB's EV-to-Revenue

For the Medical Devices subindustry, Chordate Medical Holding AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chordate Medical Holding AB's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's EV-to-Revenue falls into.



Chordate Medical Holding AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Chordate Medical Holding AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6.500/1.114
=5.83

Chordate Medical Holding AB's current Enterprise Value is kr6.50 Mil.
Chordate Medical Holding AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chordate Medical Holding AB  (OSTO:CMH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Chordate Medical Holding AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0552/0.005
=11.04

Chordate Medical Holding AB's share price for today is kr0.0552.
Chordate Medical Holding AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chordate Medical Holding AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Chordate Medical Holding AB (OSTO:CMH) Business Description

Traded in Other Exchanges
Address
c/o Regus, Kistagangen 20B, Kista, SWE, 164 40
Chordate Medical Holding AB is a medical technology company that has developed and patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients who are 18 years old or older. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB (OSTO:CMH) Headlines

No Headlines